Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$5.89 USD
+0.36 (6.51%)
Updated Oct 14, 2025 04:00 PM ET
After-Market: $5.88 -0.01 (-0.17%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Recursion Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RXRX 5.89 +0.36(6.51%)
Will RXRX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for RXRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RXRX
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains?
RXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
Other News for RXRX
Is RXRX building bullish momentum? Non-ADX 1,2,3,4 Bullish shows up after climbing 3.95%
Recursion Pharmaceuticals call volume above normal and directionally bullish
Recursion Pharmaceuticals call volume above normal and directionally bullish
Is RXRX setting up for a drop? Fell Below 200 Day Moving Average shows up after tumbling 9.98%
200 Day Moving Average Support appears for RXRX after 2.96% move